Voyager Therapeutics Inc.

NASDAQ: VYGR · Real-Time Price · USD
3.73
0.01 (0.27%)
At close: Aug 15, 2025, 3:59 PM
3.77
0.83%
After-hours: Aug 15, 2025, 07:35 PM EDT

Voyager Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-107.93M -84.69M -65M 25.88M 9.02M -3.04M 132.33M 52.31M 95.83M 98.95M -46.41M -17.07M -59.83M -70.87M -71.2M -92.83M 17.92M 39.35M
Depreciation & Amortization
2.43M 4.55M 4.73M 5.05M 4.87M 4.56M 4.44M 3.94M 4.34M 4.45M 6.19M 6.84M 6.72M 6.7M 5.17M 4.67M 4.51M 4.25M
Stock-Based Compensation
14.98M 14.88M 14.79M 14.09M 13.54M 12.17M 11.15M 10.45M 9.77M 9.58M 9.34M 8.65M 8.54M 10.04M 11.32M 13.17M 14.63M 14.49M
Other Working Capital
-7.39M -39.5M -48.84M -50.19M -45.39M -25.3M 14.36M 13.96M -12.46M -11.64M 18M 24.3M 51.13M 51.48M -1.72M -6.5M -127.04M -146.09M
Other Non-Cash Items
-18.2M -3.62M -4.68M -4.96M -4.88M -4.29M -3.45M -1.3M 458K -2.1M -2.11M -2.47M -2.33M 1.58M -2.32M -14.02M -11.01M -12.39M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 111K 213K 297K 362K 317K
Change in Working Capital
-4.93M -43.1M 34.86M -64.61M -40.17M 3.73M -66.56M 24.04M -16.11M -34.26M 20.47M 14.98M 53.33M 54.63M 3.29M 2.01M -117.13M -135.24M
Operating Cash Flow
-113.65M -111.97M -15.31M -24.54M -17.62M 13.12M 77.92M 89.44M 94.28M 76.63M -12.51M 10.93M 6.43M 2.19M -53.52M -86.7M -90.73M -89.21M
Capital Expenditures
-2.18M -2.04M -3.52M -4.12M -4.64M -4.89M -3.26M -3.43M -2.93M -2.96M -2.49M -1.91M -2.29M -1.27M -1.61M -4.82M -9.31M -10.96M
Cash Acquisitions
n/a n/a n/a -27.59M 129.93M 153.39M 153.39M 180.97M 23.45M n/a n/a -2.46M -2.46M -2.46M -2.46M n/a n/a n/a
Purchase of Investments
-286.62M -338.76M -465.69M -363.66M -489.37M -427.82M -223.97M -194.97M -28.45M -34.89M -54.85M -69.97M -69.97M -35.08M -15.12M -45.42M -55.42M -70.4M
Sales Maturities Of Investments
369.07M 383.2M 374.35M 326.96M 230.54M 180.51M 85.58M 44M 70M 65M 50M 45M 25M 47.63M 82.63M 100.13M 127.63M 120M
Other Investing Acitivies
n/a n/a n/a 27.59M -129.93M -153.39M -153.39M -165.97M 26.55M 15.11M -4.85M -17.39M -37.39M 20.13M 75.09M 72.6M 90.11M 67.51M
Investing Cash Flow
80.28M 42.41M -94.86M -40.82M -263.48M -252.2M -141.64M -154.41M 38.62M 27.15M -7.34M -26.87M -47.25M 11.28M 65.91M 49.85M 62.87M 38.63M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
434K n/a n/a n/a n/a n/a n/a 249K 249K 249K 249K 584K 584K 584K 584K 844K 844K 844K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
749K 1.24M 1.24M 1.12M 1.44M 2.42M 2.52M 2.34M 2.02M 1.28M 1.11M 1.06M 1.05M 596K 612K 871K 1.38M 3.16M
Financial Cash Flow
1.18M 1.24M 114.02M 113.9M 114.22M 115.19M 33.65M 33.46M 33.15M 32.4M 1.11M 1.06M 1.05M 596K 612K 871K 1.38M 3.16M
Net Cash Flow
-32.19M -68.32M 3.85M 48.54M -166.88M -123.88M -30.08M -31.51M 166.04M 136.18M -18.74M -14.88M -39.78M 14.07M 12.99M -35.97M -26.48M -47.43M
Free Cash Flow
-115.83M -114.01M -18.83M -28.66M -22.27M 8.23M 74.66M 86M 91.35M 73.67M -15M 9.03M 4.14M 923K -55.13M -91.52M -100.04M -100.18M